EUVIMEDEUVIMED entdecken
Crossref

MOLECULAR MARKERS OF ENDOMETRIAL RECEPTIVITY IN CLINICAL PRACTICE: POSSIBILITIES AND LIMITATIONS OF APPLICATION

Munisa Firdavsovna Abdusamatova, Taisiya Sergeevna Bakhareva, Rukizhat Shamilievna Mamaeva, Gulizar Robertovna Kurbanova, Madina Abdulkasimovna Kazibekova, Mariyat Khaibulaevna Kurbandibirova, Sayad Uzdanovna Guseynova, Elina Mayrbekovna Inarkieva

Genetics and Molecular Research · 2026 · 25 (2)

DOI: 10.4238/a2x14269 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Genetics and Molecular Research, 2026. Verfasst von Munisa Firdavsovna Abdusamatova und 7 weiteren Autor:innen.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Endometrial receptivity is regarded as one of the key conditions for successful embryo implantation, especially in assisted reproductive technology programs. Even after the transfer of morphologically high-quality embryos, pregnancy does not always occur, which increases interest in evaluating the endometrium as an independent factor influencing reproductive outcomes. The formation of a receptive state is associated with the coordinated action of hormonal regulation, immune responses, cytokine signaling, gene expression, microRNAs, protein molecules, and the local microbiota. In this regard, molecular markers of receptivity are increasingly considered as a tool for clarifying the “window of implantation” and personalizing management strategies for patients with implantation failure. The aim of this review is to analyze the possibilities and limitations of using molecular markers of endometrial receptivity in clinical practice. The review considers the main groups of markers, including transcriptomic, proteomic, immunological, epigenetic, and microbiome indicators, as well as diagnostic approaches based on their assessment, including ERA and similar molecular tests. It is shown that these methods expand the understanding of the functional state of the endometrium and may be useful for individualized embryo transfer planning; however, their clinical significance remains a matter of debate. The limitations of their application include variability of results, dependence on the day of the cycle, the influence of hormonal protocols, inflammatory processes, and concomitant gynecological diseases, as well as insufficient standardization of data interpretation. It is concluded that molecular assessment of endometrial receptivity has potential for personalized reproductive medicine, but it cannot be considered a universal method for predicting implantation without taking into account the clinical context, embryo quality, and the patient’s condition.

Zitieren

APA

Abdusamatova, M. F., Bakhareva, T. S., Mamaeva, R. S., Kurbanova, G. R., Kazibekova, M. A., Kurbandibirova, M. K., Guseynova, S. U., & Inarkieva, E. M. (2026). MOLECULAR MARKERS OF ENDOMETRIAL RECEPTIVITY IN CLINICAL PRACTICE: POSSIBILITIES AND LIMITATIONS OF APPLICATION. Genetics and Molecular Research, 25(2). https://doi.org/10.4238/a2x14269

Vancouver

Abdusamatova MF, Bakhareva TS, Mamaeva RS, Kurbanova GR, Kazibekova MA, Kurbandibirova MK, et al. MOLECULAR MARKERS OF ENDOMETRIAL RECEPTIVITY IN CLINICAL PRACTICE: POSSIBILITIES AND LIMITATIONS OF APPLICATION. Genetics and Molecular Research. 2026;25(2). doi:10.4238/a2x14269

BibTeX
@article{Abdusamatova2026,
  author = {Abdusamatova, Munisa Firdavsovna and Bakhareva, Taisiya Sergeevna and Mamaeva, Rukizhat Shamilievna and Kurbanova, Gulizar Robertovna and Kazibekova, Madina Abdulkasimovna and Kurbandibirova, Mariyat Khaibulaevna and Guseynova, Sayad Uzdanovna and Inarkieva, Elina Mayrbekovna},
  title = {MOLECULAR MARKERS OF ENDOMETRIAL RECEPTIVITY IN CLINICAL PRACTICE: POSSIBILITIES AND LIMITATIONS OF APPLICATION},
  journal = {Genetics and Molecular Research},
  year = {2026},
  volume = {25},
  number = {2},
  doi = {10.4238/a2x14269}
}
Kostenlos starten →